| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.07. | Better Prescribing, Not Less Prescribing, Is What Behavioral Health Needs | ||
| 22.07. | You Can Now Bet on Clinical Trials Like Playoff Games, But Health Execs Say It Crosses a Line | ||
| 22.07. | New Bill Seeks to Create Public Option on ACA Marketplaces | ||
| 21.07. | Agios Pharma Drops Sickle Cell Disease Drug After Phase 2 Data Disappoint | ||
| 21.07. | How Diagnostic Precision in Allergy Care Supports Mental Well-Being | ||
| 21.07. | Why Pharma Companies Should Look To Social Media For Better Patient Insight | ||
| 21.07. | Where Will AI Deployment Benefit Payers the Most? | ||
| 21.07. | The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says | ||
| 21.07. | How Should Clinical AI Be Paid For? 3 Takeaways | ||
| 20.07. | Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis | ||
| 20.07. | The AI Tension in Healthcare: Patent Strategy, FDA Reality, and HIPAA Constraints | ||
| 20.07. | For Millions in Rural America, Medicine Is Still Far Away | ||
| 20.07. | Women's Oncology Market Could Reach $110B in 2030, but Gaps Remain | ||
| 19.07. | Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs | ||
| 19.07. | Hybrid Financing in Life Sciences: Unlocking Growth Amid Market Challenges | ||
| 19.07. | Are We Entering an Interoperability Trust Recession? | ||
| 17.07. | Juno Bio Raises $3.8M to Support Vaginal Health | ||
| 17.07. | The 'Bot Vs. Bot' Dynamic Between Providers & Payers Is Driving Up Costs for Everyone | ||
| 17.07. | GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough | ||
| 17.07. | Why Specialty-Specific Measurement and Intervention Are Essential to Address Healthcare Burnout | ||
| 17.07. | Why Settle for Acceptable Versus Optimal Outcomes? | ||
| 17.07. | Healthcare Groups Praise Unanimous Committee Approval of MA Prior Auth Bill | ||
| 16.07. | Why CMS Is Trying to Ban Third-Party Remote Patient Monitoring | ||
| 16.07. | Lilly Expands Its Mind to Psychedelics With $2.8B AtaiBeckley Acquisition | ||
| 16.07. | What Happens to Independent Medicine When Private Equity Shows Up With a Checkbook |